nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Browsing articles in "Anxiety/Stress-Related Disorders"

 

Addressing Mental Healthcare in the LGBTQ Community
June 11, 2021   

NEI sat down with Drs. Rhonda Schwindt and Dr. Stephen Forssell for an expert discussion on disparities in the mental health care of lesbian, gay, bisexual, transgender and queer/questioning (LGBTQ) individuals...
 Continue reading
Children With Congenital Heart Disease at Elevated Risk of Depression, Anxiety, ADHD
January 26, 2021   

A recent comparative cross-sectional study was conducted to examine the risk of mental health disorders (e.g. depression, anxiety, and attention deficit/hyperactivity disorder) in youth with congenital heart disease (CHD). Data was collected from...
 Continue reading (Members only)
Ketamine Infusions May Rapidly Reduce Chronic PTSD Symptoms
January 23, 2021   

Previous research suggests that a single-dose of intravenous ketamine infusion results in significant and rapid reduction of posttraumatic stress disorder symptoms . Building on these findings, in a recent randomized controlled trial, repeated administration of ketamine infusions was tested for...
 Continue reading
Managing Chronic Stress, the Holidays, and the Pandemic with Dr. Jennifer Love
December 10, 2020   

How can someone tell whether they are experiencing chronic levels of stress? How has the change in the family structure affected the way that most will celebrate the holidays this year and affect the levels of chronic stress that we’re experiencing?...
 Continue reading
Bidirectional Genetic Associations Between Prescription Opioid Use And Major Depressive Disorder
December 7, 2020   

Opioid use is often comorbid with major depressive disorder and anxiety and stress-related disorders. Determining the direction and potentially causative effects of these associations would be valuable to prevention strategies. Mendelian randomization, which uses single nucleotide variants as unconfounded proxies for exposures to estimate...
 Continue reading
FDA Approves PTSD Sleep Device for Nightmares
November 11, 2020   

The U.S. Food and Drug Administration granted marketing authorization of a new device intended for the temporary reduction of sleep disturbance related to nightmares in adults who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder...
 Continue reading
FDA Requiring Stronger Warning Label For Benzodiazepines
September 25, 2020   

The US Food and Drug Administration has ordered changes to the labeling for benzodiazepines, requiring them to include information on the risks of abuse, misuse, addiction, physical dependence, and withdrawal reactions. Benzodiazepines are...
 Continue reading
NEI Virtual Poster Library is Live!
July 13, 2020   

NEI has launched a Virtual Poster Library to fulfill the needs of poster presenters who had hoped to share their research and findings at medical conferences that have been cancelled due to the COVID-19 pandemic....
 Continue reading
Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus
April 9, 2020   

With the rising rates of COVID-19 (i.e., severe acute respiratory syndrome coronavirus 2) infection and hospitalization across the world, frontline health care workers will continue to face an overwhelming workload throughout the course of this pandemic. This workload, along with the depletion of personal protection equipment, widespread media coverage, lack of specific drugs and feelings of being inadequately supported may contribute to adverse psychological reactions...
 Continue reading
FDA Bans Electrical Stimulation Devices for Self-Injurious or Aggressive Behavior
March 23, 2020   

The U.S. Food and Drug Administration (FDA) bans electrical stimulation devices used for self-injurious or aggressive behavior because they present...
 Continue reading (Members only)
1234
Top of Page